Launch Excellence, Delivered – Avira Life Sciences

Driving Launch Excellence with Medical 360

This case study shows how a top global pharmaceutical company used Medical 360 to bring clarity, alignment, and real-time visibility to a critical product launch. By connecting medical strategy directly to execution and outcomes, the organization replaced fragmented planning and retrospective reporting with a unified, data-driven launch model- enabling faster decisions and greater confidence during the most critical phase of commercialization.

Client

A top global pharmaceutical company preparing for the launch of a high-priority asset and seeking stronger alignment between medical strategy and on-the-ground execution.

Business Challenge

As launch preparations intensified, the organization faced common-but critical-challenges:

Strategic imperatives such as real-world evidence (RWE) generation, HCP education, and biomarker strategy were defined, but not consistently linked to measurable objectives or tactics.

Medical, Commercial, Access, and Evidence teams operated in silos, with plans scattered across presentations, spreadsheets, and shared drives.

Leadership lacked real-time visibility into whether Field Medical activities were tracking against the Medical Plan—and whether those efforts were delivering impact.

Manual, retrospective reporting meant risks and gaps were identified too late to course-correct during the high-pressure launch window.

Our Approach

The company deployed Medical 360 as a single source of truth for medical launch planning, execution, and performance tracking.

Within the platform:

Strategic Imperatives and Medical Objectives were clearly defined and translated into measurable, trackable goals.

Cross-functional alignment ensured every activity—from congress strategy to HCP education and post-launch studies—was directly linked to the medical plan.

Prioritization and visibility highlighted which objectives contributed most to each imperative, helping leaders focus resources on the highest-impact launch drivers.

Real-time dashboards tracked execution status across activities, providing continuous visibility into progress and gaps.

Closed-loop insights captured outcomes such as HCP feedback, data dissemination, and study progress—enabling teams to adapt strategies mid-launch.

Impact

Clear strategic line of sight from imperatives to objectives to execution.

Faster course correction, with risks and gaps addressed in real time.

Stronger cross-functional alignment across Medical, Commercial, and Access teams.

Greater leadership confidence with measurable visibility into Medical Affairs impact during launch.

Significant efficiency gains, saving ~20,000 hours in the first year and enabling a 35% upfront reduction in manual effort.